Cargando…
Identification of markers of prostate cancer progression using candidate gene expression
BACKGROUND: Metastatic prostate cancer (PCa) has no curative treatment options. Some forms of PCa are indolent and slow growing, while others metastasise quickly and may prove fatal within a very short time. The basis of this variable prognosis is poorly understood, despite considerable research. Th...
Autores principales: | Larkin, S E T, Holmes, S, Cree, I A, Walker, T, Basketter, V, Bickers, B, Harris, S, Garbis, S D, Townsend, P A, Aukim-Hastie, C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3251845/ https://www.ncbi.nlm.nih.gov/pubmed/22075945 http://dx.doi.org/10.1038/bjc.2011.490 |
Ejemplares similares
-
Detection of candidate biomarkers of prostate cancer progression in serum: a depletion-free 3D LC/MS quantitative proteomics pilot study
por: Larkin, S E T, et al.
Publicado: (2016) -
Asporin is a stromally expressed marker associated with prostate cancer progression
por: Rochette, Annie, et al.
Publicado: (2017) -
Identification of degradome components associated with prostate cancer progression by expression analysis of human prostatic tissues
por: Riddick, A C P, et al.
Publicado: (2005) -
Identification of claudin-4 as a marker highly overexpressed in both primary and metastatic prostate cancer
por: Landers, K A, et al.
Publicado: (2008) -
C4.4A as a candidate marker in the diagnosis of colorectal cancer
por: Paret, C, et al.
Publicado: (2007)